Dodecaborate anions represent a suitable boron source for boron neutron capture therapy (BNCT). Sugar derivatives of dodecaborate have been prepared through the ringopening reaction of cyclic oxonium ions by alkoxide nucleophiles. According to this general approach, a convenient and short synthesis of three derivatives of dodecaborate-sugar conjugates is herein reported. Glucose, galactose and fructose have 10 B(n, α) 7 Li capture reaction in reasonable time. [1] Until 2014, the neutron sources were limited to nuclear reactors that produced thermal and epithermal neutrons, but recently new accelerator-based neutron sources have been developed and are currently in use in Phase II clinical trials in Japan to evaluate their safety and efficacy. [2] Clinical interest in BNCT focused on scarcely responsive tumors to conventional therapies such as gliomas, [3] tumors of the head and neck region [4] or melanomas. [5] The BNCT treatment requires compounds able to deliver boron to the malignant cells. A suitable delivery agent should [a] 7228 Scheme 1. Optimization of the nucleophilic oxonium ion opening; a) NaH, CH 3 CN then CsF, MeOH.